IBRNvsIBTF
iShares Neuroscience and Healthcare ETF against iShares iBonds Dec 2025 Term Treasury ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBRN | IBTF | |
|---|---|---|
| Expense ratio | 0.47% | 0.070% |
| Assets | $6M | $1.4B |
| Net flow, 1 month | −$60K | — |
| Net flow, 1 year | +$2M | −$367M |
| Return, YTD | -0.9% | — |
| Return, 1 year | +15.3% | 0.0% |
| Avg daily volume | 2K | — |
| Holdings | 54 | 32 |
| Listed | Aug 24, 2022 | Feb 25, 2020 |
| Options market | Yes | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS